Thoraflex™ Hybrid THP2224X100BRecalls & reported problems
Vascutek Ltd · Thoraflex Hybrid Plexus · Class 3 · Implant
All models of Thoraflex Hybrid (33)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 05037881031712), received between Jul 15, 2026 and Jul 21, 2026 — classified as 3 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Insufficient Device Problem Information1
- Patient Device Interaction Problem1
Patient problems
- Aortic dissection2
- Thrombosis/Thrombus1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJul 21, 2026Insufficient Device Problem Information
EVENTS REPORTED FROM INSEL GRUPPE AG - 3064, VIA SWISSMEDIC REPORT. EVENTS REPORTED AS THROMBUS AFTER FROZEN ELEPHANT TRUNK. THROMBUS AT THE DISTAL STENT END OF THE FROZEN ELEPHANT TRUNK IS A WELL-KNOWN COMPLICATION. IN THE LITERATURE, THE INCIDENCE IS GIVEN AS ABOUT 8-16%. RECENTLY, WE HAVE HAD THE IMPRESSION THAT THIS COMPLICATION IS OCCURRING MORE OFTEN IN OUR COUNTRY. THE SITE COMPILED THE CASES OF THE LAST THREE MONTHS, IT WAS FOUND THAT 5 OUT OF 12 PATIENTS HAD A DISTAL THROMBUS, WHICH IS SIGNIFICANTLY HIGHER THAN THE RATE DESCRIBED IN THE LITERATURE. THIS IS SIGNIFICANTLY HIGHER THAN THE RATE DESCRIBED IN THE LITERATURE. IN ADDITION, THERE WAS A CASE WITH SERIOUS CLINICAL CONSEQUENCES LAST NOVEMBER. DESPITE CAREFUL INTRA-OPERATIVE MEASURES AND ESTABLISHED AVOIDANCE STRATEGIES ON OUR PART, THROMBI FORMATION CONTINUES TO OCCUR, WHICH IS WHY WE WOULD LIKE TO REPORT THIS.
Patient problems: Thrombosis/Thrombus
MAUDE report 25887392 ↗InjuryJul 16, 2026Adverse Event Without Identified Device or Use Problem
EVENT REPORTED BY THOR - (B)(4). PATIENT (B)(6), A WHITE MALE WITH AORTIC CHRONIC DISSECTION, EXPERIENCED AN EVENT OF DSINE (DISTAL STENT GRAFT INDUCED NEW ENTRY). THE PATIENT UNDERWENT AN OPEN SURGICAL REPLACEMENT OF THE AORTA WITH A THORAFLEX HYBRID PLEXUS DEVICE ON (B)(6) 2021. ON POST OPERATIVE DAY 369 ((B)(6)2022), PATIENT (B)(6) HAD AN AE (ADVERSE EVENT) OF DSINE (ON CT SCAN FROM (B)(6) 2022 WAS A DSINE DETECTABLE). TREATMENT OF THIS AE INCLUDED REINTERVENTION, TEVAR (THORACIC ENDOVASCULAR AORTIC REPAIR) -IMPLANTATION ON (B)(6) 2022. THE AE WAS CONSIDERED RESOLVED ON (B)(6) 2022 AND THE PATIENT CONTINUED IN THE STUDY.
Patient problems: Aortic dissection
MAUDE report 25835011 ↗InjuryJul 15, 2026Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem
EVENT REPORTED BY THOR - (B)(4). PATIENT 027, A WHITE FEMALE WITH AORTIC CHRONIC DISSECTION, EXPERIENCED AN EVENT OF DSINE( DISTAL STENT GRAFT INDUCED NEW ENTRY). THE PATIENT UNDERWENT AN OPEN SURGICAL REPLACEMENT OF THE AORTA WITH A THORAFLEX HYBRID PLEXUS DEVICE ON (B)(6) 21. ON POST OPERATIVE DAY 384 ((B)(6) 22), PATIENT 027 HAD AN AE(ADVERSE EVENT) OF DSINE (ON CT SCAN FROM (B)(6).2022 WAS A DSINE DETECTABLE). TREATMENT OF THIS AE INCLUDED REINTERVENTION, TEVAR(THORACIC ENDOVASCULAR AORTIC REPAIR) -IMPLANTATION ON (B)(6) 23. THE EVENT WAS CONSIDERED RESOLVED ON 11-MAY-23 AND THE PATIENT CONTINUED IN THE STUDY.
Patient problems: Aortic dissection
MAUDE report 25824770 ↗
Other Hybrid stent graft, thoracic aortic lesion treatment devices
- Thoraflex™ Hybrid THP3032X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment3 deaths8 reports
- Thoraflex™ Hybrid THP3036X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment7 reports
- Thoraflex™ Hybrid THP3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THA3036X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THP2830X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment4 reports
- Thoraflex™ Hybrid THP3036X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment1 death3 reports
- Thoraflex™ Hybrid THA3032X150AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment2 deaths3 reports
- Thoraflex™ Hybrid THA2830X100AVascutek Ltd · Hybrid stent graft, thoracic aortic lesion treatment1 death3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page